Seamless Therapeutics
Dresden
About Seamless Therapeutics
Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $25.2M
- Funding stage: Seed
- Last round: Seed (Apr 2024)
- Website: seamlesstx.com
- Phone: +49 351 212 469 00
Industries & Categories
Genetics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/seamless-therapeutics-23507 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.